6287 search
Myriad Genetics
NASDAQ MYGN 28,12 US$ 46,92%
Logo

[$$] Myriad Genetics' Profit Rises on Higher Sales of DNA Tests

Publié le 03 novembre 2015

Pour voir l'article original, cliquez ici .

Les autres articles de la compagnie
5 Hated Stocks Set to Soar on Bullish Earnings
Myriad Genetics Shares May Hit $50
Huge Biotech Index Rebalance Means Massive Buy Orders for 5
Two Picks in Small-Cap Pharma With Catalysts
Dozens of Genes in Breast Cancer Tests Have Tenuous Link to
Articles en illimité et contenus premium Je m'abonne
Editoriaux
et Nouvelles
Actions
Minières
Or et
Argent
Marchés La Cote
search 6287
search